Professor Kittiyod Poovorawan
Contact information
Research groups
Kittiyod Poovorawan
Associate Professor and Research Physician
An Associate Professor in the Department of Clinical Tropical Medicine, Faculty of Tropical Medicine (FTM) at Mahidol University in Bangkok, Kittiyod Poovorawan has been a member of MORU’s Clinical Therapeutics Unit (CTU) since 2019.
A Thai medical doctor board-certified in internal medicine and gastroenterology, Kittiyod has expertise in internal medicine, gastroenterology, hepatology, and clinical research of tropical diseases.
Kittiyod specialises in both teaching and clinical research. He teaches students from the Diploma, MSc, and PhD courses at the Bangkok School of Tropical Medicine, works as a gastroenterology consultant physician, and is the deputy director of the Hospital for Tropical Diseases in Bangkok.
Kittiyod’s primary research area is liver diseases including viral hepatitis, liver abscess, chronic liver disease, and gastrointestinal involvement in tropical diseases. He is experienced in conducting clinical trials on viral hepatitis and tropical infectious diseases. He is a part of an active clinical research team, conducting several research projects including pharmacological studies of antimalarial, platform studies in COVID-19, and The Malaria Infection Study in Thailand (MIST).
Kittiyod has published more than 60 international peer-reviewed research articles and his current and future research focusses on tropical infectious diseases and viral hepatitis elimination.
Recent publications
-
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers.
Journal article
Pukrittayakamee S. et al, (2024), eLife, 12
-
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of phase 2 antiviral studies
Preprint
Wongnak P. et al, (2024)
-
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
Journal article
Jittamala P. et al, (2023), The Journal of Infectious Diseases, 228, 1318 - 1325
-
Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand.
Journal article
Janekrongtham C. et al, (2023), BMJ open, 13
-
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Journal article
Schilling WHK. et al, (2023), eLife, 12